A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma

Published:2024-06 Issue: Volume:3 Page:100159
ISSN:2772-610X
Container-title:EJC Paediatric Oncology
language:en
Short-container-title:EJC Paediatric Oncology

Author:

Samim Atia^ORCID,Bleeker Gitta,Kraal Kathelijne C.J.M.,van Noesel Max M.,de Keizer Bart^ORCID,Tytgat Godelieve A.M.

Publisher

Elsevier BV

Reference38 articles.

1. Neuroblastoma between 1990 and 2014 in the Netherlands: increased incidence and improved survival of high-risk neuroblastoma;Tas;Eur. J. Cancer,2020

2. Advances in risk classification and treatment strategies for neuroblastoma;Pinto;J. Clin. Oncol.,2015

3. I-131-mIBG therapy in neuroblastoma: established role and prospective applications;Schmidt;Clin. Transl. Imaging,2016

4. 123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: results from a prospective multicenter trial;Vik;Pedia Blood Cancer,2009

5. 131I-Metaiodobenzylguanidine theranostics in neuroblastoma: historical perspectives; practical applications;Parisi;Semin Nucl. Med,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP